| Filed On | Filing |
|---|---|
| 06 May 2026 |
Form 4: Novo Holdings A/S, 10% owner · Hemab Therapeutics Holdings Inc
Received 4,180,550 shares by conversion |
| 05 May 2026 |
Form 4: Novo Holdings A/S, 10% owner · Avalyn Pharma Inc
Received 3,327,734 shares by conversion · Bought 555,555 shares ($10M) |
| 30 Oct 2025 |
Form 4: Novo Holdings A/S, 10% owner · MapLight Therapeutics, Inc.
Received 2,733,681 shares by conversion · Bought 952,941 shares ($16.2M) |
| 26 Jul 2024 |
Form 4: Novo Holdings A/S, 10% owner · IO Biotech, Inc.
Sold 51,522 shares ($68.3K) · Sold 23,478 shares ($30.8K) |
| 14 May 2024 |
Form 4: Novo Holdings A/S, 10% owner · IO Biotech, Inc.
Sold 658,809 shares ($802K) |
| 25 Mar 2024 |
Form 4: Novo Holdings A/S, 10% owner · Spruce Biosciences, Inc.
Sold 465,021 shares ($351K) |
| 20 Mar 2024 |
Form 4: Novo Holdings A/S, 10% owner · Spruce Biosciences, Inc.
Sold 842,020 shares ($647K) · Sold 593,000 shares ($448K) · Sold 359,979 shares ($264K) |
| 18 Mar 2024 |
Form 4: Novo Holdings A/S, 10% owner · Spruce Biosciences, Inc.
Sold 1,912,316 shares ($1.7M) |
| 15 Feb 2024 |
Form 4: Novo Holdings A/S, 10% owner · Metagenomi Therapeutics Inc
Bought 100,000 shares ($1.03M) · Received 839,175 shares by conversion · Bought 800,000 shares ($12M) |
| 13 Feb 2024 |
Form 4: Novo Holdings A/S, 10% owner · IO Biotech, Inc.
Sold 658,809 shares ($988K) |
| 11 Aug 2023 |
Form 4: Novo Holdings A/S, 10% owner · IO Biotech, Inc.
Bought 2,469,135 shares ($5M) · Acquired 2,469,135 Common Stock Warrant (Right to Buy) (Open Market Purchase) ($5M) |
| 20 Jul 2023 |
Form 4: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
Sold 1,900 shares ($5.25K) · Sold 100,000 shares ($275K) |
| 18 Jul 2023 |
Form 4: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
Sold 11,000 shares ($30.1K) · Sold 21,100 shares ($58K) · Sold 6,500 shares ($17.9K) |
| 03 Jul 2023 |
Form 4: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
Sold 200,937 shares ($529K) |
| 28 Jun 2023 |
Form 4: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
Sold 8,437 shares ($15.1K) · Sold 31,978 shares ($56.7K) |
| 28 Jun 2023 |
Form 4: Novo Holdings A/S, 10% owner · Disc Medicine, Inc.
Sold 1,250,000 shares ($57.6M) |
| 23 Jun 2023 |
Form 4: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
Sold 4,834 shares ($9.64K) · Sold 5,041 shares ($9.78K) · Sold 3,423 shares ($6.45K) |
| 23 Jun 2023 |
Form 4: Novo Holdings A/S, 10% owner · Onkure Therapeutics Inc
Sold 100,000 shares ($710K) |
| 20 Jun 2023 |
Form 4: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
Sold 10,002 shares ($20.3K) · Sold 5,983 shares ($12.1K) · Sold 744 shares ($1.57K) |
| 14 Jun 2023 |
Form 4: Novo Holdings A/S, 10% owner · Cyteir Therapeutics, Inc.
Sold 900 shares ($1.86K) · Sold 2,626 shares ($5.51K) · Sold 2,872 shares ($6.05K) |
Loading...